Voyager Therapeutics (VYGR) Tops Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Join SI Premium – FREE
Voyager Therapeutics (NASDAQ: VYGR) reported Q2 EPS of ($0.18), $0.23 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $29.58 million versus the consensus estimate of $9.51 million.
For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Qualcomm (QCOM) PT Raised to $195 at BofA Securities
- Lockheed Martin wins $83 million Army missile contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
